1.35 USD
0 (0%)
1.32 USD
-0.03 (-2.22%)
ChartMill assigns a Buy % Consensus number of 43% to GMTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.53. This target is 13.33% above the current price.
GMTX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about GMTX.
In the previous month the buy percentage consensus was at a similar level.
GMTX was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-03-11 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-03-03 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-03-01 | Jefferies | Downgrade | Buy -> Hold |
| 2022-01-24 | SVB Leerink | Maintains | Outperform |
| 2021-12-20 | SVB Leerink | Maintains | Outperform |
| 2021-12-15 | HC Wainwright & Co. | Initiate | Buy |
| 2021-10-06 | Goldman Sachs | Maintains | Buy |
| 2021-04-08 | SVB Leerink | Initiate | Outperform |
| 2021-03-03 | Jefferies | Initiate | Buy |
| 2021-03-02 | Goldman Sachs | Initiate | Buy |
GEMINI THERAPEUTICS INC / GMTX FAQ
What is the average price target for GEMINI THERAPEUTICS INC (GMTX) stock?
6 analysts have analysed GMTX and the average price target is 1.53 USD. This implies a price increase of 13.33% is expected in the next year compared to the current price of 1.35.
Can you provide the consensus rating for GEMINI THERAPEUTICS INC stock?
The consensus rating for GEMINI THERAPEUTICS INC (GMTX) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts cover GEMINI THERAPEUTICS INC (GMTX) stock?
The number of analysts covering GEMINI THERAPEUTICS INC (GMTX) is 6.